This study elaborates on the risk factors for bleeding during extracorporeal membrane oxygenation (ECMO) in adults, the prevention and management of acute bleeding, and meticulous post bleeding nursing care. It serves as a reference for predicting bleeding risk factors and personalized anticoagulation protocols in patients receiving ECMO, ultimately aiming to advance ECMO anticoagulation management toward precision and standardization.

1. 周利平, 黄国庆, 李湘民, 等. 体外膜肺氧合治疗期间出血和血栓事件的危险因素分析[J]. 中华急诊医学杂志, 2023, 32(9): 1226-1234. [Zhou LP, Huang GQ, Li XM, et al. Risk factors for bleeding and thrombotic events in critically ill patients undergoing extracorporeal membrane oxygenation[J]. Chinese Journal of Emergency Medicine, 2023, 32(9): 1226-1234.] DOI: 10.3760/cma.j.issn.1671-0282.2023.09.014.

2. Petros S. Pathophysiologie der blutung [pathophysiology of bleeding][J]. Med Klin Intensivmed Notfmed, 2021, 116(6): 475-481. DOI: 10.1007/s00063-021-00844-x.

3. Maier CL, Brohi K, Curry N, et al. Contemporary management of major haemorrhage in critical care[J]. Intensive Care Med, 2024, 50(3): 319-331. DOI: 10.1007/s00134-023-07303-5.

4. Helms J, Frere C, Thiele T, et al. Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the scientific and standardization committees on perioperative and critical care haemostasis and thrombosis of the international society on thrombosis and haemostasis[J]. J Thromb Haemost, 2023, 21(2): 373-396. DOI: 10.1016/j.jtha.2022.11.014.

5. Esper SA, Levy JH, Waters JH, et al. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion[J]. Anesth Analg, 2014, 118(4): 731-743. DOI: 10.1213/ANE.0000000000000115.

6. 尹小雪, 叶钢. 成人外周置管体外膜肺氧合支持过程中出血并发症的危险因素探讨[J]. 临床急诊杂志, 2024, 25(7): 348-351. [Yin XX, Ye G. To investigate the risk factors of bleeding complications during peripherally inserted extracorporeal membrane oxygenation support in adults[J]. Journal of Clinical Emergency, 2024, 25(7): 348-351.] DOI: 10.13201/j.issn.1009-5918.2024.07.005.

7. Willers A, Swol J, Van kuijk SMJ, et al. HEROES V-V-HEmorRhagic cOmplications in veno-venous extracorporeal life support-development and internal validation of multivariable prediction model in adult patients[J]. Artif Organs, 2022, 46(5): 932-952. DOI: 10.1111/aor.14148.

8. Oude Lansink-hartgring A, de Vries AJ, Droogh JM, et al. Hemorrhagic complications during extracorporeal membrane oxygenation - the role of anticoagulation and platelets[J]. J Crit Care, 2019, 54: 239-243. DOI: 10.1016/j.jcrc.2019.09.013.

9. Kalbhenn J, Zieger B. Bleeding during veno-venous ECMO: prevention and treatment[J]. Front Med (Lausanne), 2022, 9: 879579. DOI: 10.3389/fmed.2022.879579.

10. Ried M, Sommerauer L, Lubnow M, et al. Thoracic bleeding complications in patients with venovenous extracorporeal membrane oxygenation[J]. Ann Thorac Surg, 2018, 106(6): 1668-1674. DOI: 10.1016/j.athoracsur.2018.07.020.

11. Nunez JI, Gosling AF, O'Gara, et al. Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis[J]. Intensive Care Med, 2022, 48(2): 213-224. DOI: 10.1007/s00134-021-06593-x.

12. Hu Z, Peng M, Dong C, et al. Risk factors and economic burden of healthcare-associated infections among patients supported by extracorporeal membrane oxygenation in the ICU: a cohort study from China[J]. Antimicrob Resist Infect Control, 2025, 14(1): 91. DOI: 10.1186/s13756-025-01611-9.

13. Willers A, Swol J, Kowalewski M, et al. Extracorporeal life support in hemorrhagic conditions: a systematic review[J]. ASAIO J, 2021, 67(5): 476-484. DOI: 10.1097/mat.0000000000001216.

14. Trieu NHK, Mai TA, Pham HM. Critical hematological parameters in bleeding during extracorporeal membrane oxygenation support[J]. J Artif Organs, 2025, 28(1): 25-29. DOI: 10.1007/s10047-024-01466-8.

15. 张秋阳, 余韶芸, 潘向滢, 等. 成年体外膜肺氧合患者出血影响因素的Meta分析[J]. 中华危重症医学杂志（电子版）, 2024, 17(5): 392-398. [Zhang QY, Yu SY, Pan XY, et al. Risk factors for hemorrhage in adult patients with extracorporeal membrane oxygenation: a meta-analysis[J]. Chinese Journal of Critical Care Medicine (Electronic Edition), 2024, 17(5): 392-398.] DOI: 10.3877/cma.j.issn.1674-6880.2024.05.006.

16. Walker EA, Roberts AJ, Louie EL, et al. Bivalirudin dosing requirements in adult patients on extracorporeal life support with or without continuous renal replacement therapy[J]. ASAIO J, 2019, 65(2): 134-138. DOI: 10.1097/mat.0000000000000780.

17. Robba C, Ortu A, Bilotta F, et al. Extracorporeal membrane oxygenation for adult respiratory distress syndrome in trauma patients: a case series and systematic literature review[J]. J Trauma Acute Care Surg, 2017, 82(1): 165-173. DOI: 10.1097/ta.0000000000001276.

18. Mansour A, Flecher E, Schmidt M, et al. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study[J]. Intensive Care Med, 2022, 48(8): 1039-1052. DOI: 10.1007/s00134-022-06794-y.

19. Cashen K, Meert K, Dalton HJ. Platelet count and function during pediatric extracorporeal membrane oxygenation[J]. Semin Thromb Hemost, 2020, 46(3): 357-365. DOI: 10.1055/s-0040-1708542.

20. Rajsic S, Breitkopf R, Rugg C, et al. Thrombotic events develop in 1 out of 5 patients receiving ECMO support: an 11-year referral centre experience[J]. J Clin Med, 2023, 12(3): 1082. DOI: 10.3390/jcm12031082.

21. Rajsic S, Breitkopf R, Jadzic D, et al. Anticoagulation strategies during extracorporeal membrane oxygenation: a narrative review[J]. J Clin Med, 2022, 11(17): 5147. DOI: 10.3390/jcm11175147.

22. Robinson RC, Taylor AN, Cato AW, et al. Low versus standard intensity heparin protocols in adults maintained on extracorporeal membrane oxygenation: a retrospective cohort study[J]. J Pharm Pract, 2025, 38(3): 299-304. DOI: 10.1177/08971900241285248.

23. Raman J, Alimohamed M, Dobrilovic N, et al. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation[J]. J Heart Lung Transplant, 2019, 38(4): 433-439. DOI: 10.1016/j.healun.2019.01.1313.

24. Song K, Kim JB. Safety of low-dose anticoagulation in extracorporeal membrane oxygenation using the permanent life support system: a retrospective observational study[J]. J Yeungnam Med Sci, 2023, 40(3): 276-282. DOI: 10.12701/jyms.2023.00339.

25. Scaravilli V, Fumagalli J, Rosso L, et al. Heparin-free lung transplantation on venovenous extracorporeal membrane oxygenation bridge[J]. ASAIO J, 2021, 67(11): e191-e197. DOI: 10.1097/mat.0000000000001371.

26. Sattler LA, Boster JM, Ivins-O'Keefe KM, et al. Argatroban for anticoagulation in patients requiring venovenous extracorporeal membrane oxygenation in coronavirus disease 2019[J]. Crit Care Explor, 2021, 3(9): e0530. DOI: 10.1097/cce.0000000000000530.

27. Wieruszewski PM, Macielak SA, Nei SD, et al. Heparin versus bivalirudin for anticoagulation in adult extracorporeal membrane oxygenation: a systematic review and Meta-analysis[J]. ASAIO J, 2023, 69(2): 137-144. DOI: 10.1097/mat.0000000000001808.

28. Li DH, Sun MW, Zhang JC, et al. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis[J]. Thromb Res, 2022, 210: 53-62. DOI: 10.1016/j.thromres.2021.12.024.

29. 谢永鹏, 骆继业, 李吉光, 等. 危重型新型冠状病毒肺炎患者合并肝素抵抗2例[J]. 中华危重病急救医学, 2022, 34(5): 509-513. [Xie YP, Luo JY, Li JG, et al. Critical coronavirus disease 2019 complicated with heparin resistance in 2 patients  [J]. Chinese Critical Care Medicine, 2022, 34(5): 509-513.] DOI: 10.3760/cma.j.cn121430-20220106-00012.

30. Capecchi M, Novembrino C, Abbattista M, et al. Involvement of the contact pathway in COVID-19 coagulopathy[J]. Intern Emerg Med, 2025. DOI: 10.1007/s11739-025-04191-z.

31. Herb A, Wimmer J, Mauvieux L, et al. Pitfalls in argatroban monitoring: heparin interference with dilute thrombin time assays[J]. Int J Lab Hematol, 2025, 47(5): 989-991. DOI: 10.1111/ijlh.14505.

32. Buckley LF, Reardon DP, Camp PC, et al. Aminocaproic acid for the management of bleeding in patients on extracorporeal membrane oxygenation: four adult case reports and a review of the literature[J]. Heart Lung, 2016, 45(3): 232-236. DOI: 10.1016/j.hrtlng.2016.01.011.

33. 乔莉, 张奇峰, 张双龙, 等. 体外膜氧合联合连续性肾脏替代治疗患者的临床特点及抗凝治疗[J]. 中国体外循环杂志, 2025, 23(2): 113-117. [Qiao L, Zhang QF, Zhang SL, et al. Clinical characteristics and anticoagulation therapy of patients with extracorporeal membrane oxygenation combined with continuous renal replacement therapy[J]. Chinese Journal of Extracorporeal Circulation, 2025, 23(2): 113-117.] DOI: 10.13498/j.cnki.chin.j.ecc.2025.02.05.

34. Tonetti T, Zanella A, Pérez-Torres D, et al. Current knowledge gaps in extracorporeal respiratory support[J]. Intensive Care Med Exp, 2023, 11(1): 77. DOI: 10.1186/s40635-023-00563-x.

35. Balle CM, Jeppesen AN, Christensen S, et al. Platelet function during extracorporeal membrane oxygenation in adult patients[J]. Front Cardiovasc Med, 2019, 6: 114. DOI: 10.3389/fcvm.2019.00114.

36. Baldetti L, Nardelli P, Ajello S, et al. Anti-thrombotic therapy with cangrelor and bivalirudin in venoarterial extracorporeal membrane oxygenation patients undergoing percutaneous coronary intervention: a single-center experience[J]. ASAIO J, 2023, 69(7): e346-e350. DOI: 10.1097/mat.0000000000001871.

37. Carmona CA, Bain J, Karam O. Concordance and discordance of anticoagulation assays in children supported by ECMO: the truth is out there[J]. Perfusion, 2025, 40(7): 1592-1599. DOI: 10.1177/02676591241309841.

38. Li S, Li A, Beckman JA, et al. Discordance between aPTT and anti-Xa in monitoring heparin anticoagulation in mechanical circulatory support[J]. ESC Heart Fail, 2024, 11(5): 2742-2748. DOI: 10.1002/ehf2.14816.

39. Szułdrzyński K, Jankowski M, Fleming M. Systemic coagulation derangement as an early sign of oxygenator failure in veno-venous extracorporeal membrane oxygenation (VV ECMO) without anticoagulation[J]. Reports (MDPI), 2024, 7(4): 97. DOI: 10.3390/reports7040097.

40. Vajter J, Volod O. Anticoagulation management during ECMO: narrative review[J]. JHLT Open, 2025, 8: 100216. DOI: 10.1016/j.jhlto.2025.100216.

41. Krajewski S, Kurz J, Geisler T, et al. Combined blockade of ADP receptors and PI3-kinase p110β fully prevents platelet and leukocyte activation during hypothermic extracorporeal circulation[J]. PLoS One, 2012, 7(6): e38455. DOI: 10.1371/journal.pone.0038455.

42. AL-fares A, Pettenuzzo T, Del Sorbo L. Extracorporeal life support and systemic inflammation[J]. Intensive Care Med Exp, 2019, 7(Suppl 1): 46. DOI: 10.1186/s40635-019-0249-y.

43. 席立锋, 马丕波, 贾伟, 等. 国内体外膜肺氧合技术研究进展[J]. 纺织学报, 2024, 45(8): 234-240. [Xi LF, Ma PB, Jia W, et al. Research progress of extracorporeal membrane oxygenation technology in China[J]. Journal of Textile Research, 2024, 45(8): 234-240.] DOI: 10.13475/j.fzxb.20230806202.

44. Rim G, Hyun K, Cho DG, et al. Early thrombus detection in the extracorporeal membrane oxygenation circuit by noninvasive real-time ultrasonic sensors[J]. Sci Rep, 2024, 14(1): 10438. DOI: 10.1038/s41598-024-59873-z.

45. Wang Y, Zhang W, Chen X, et al. Extracorporeal membrane oxygenation treatment for severe asthma had unexpected adverse effects: a case report[J]. Front Med (Lausanne), 2023, 10: 1294421. DOI: 10.3389/fmed.2023.1294421.

46. 郭小靖, 盖玉彪, 王伟, 等. 体外膜肺氧合患者抗凝及出血风险管理的最佳证据总结[J]. 中华危重病急救医学, 2023, 35(9): 963-967. [Guo XJ, Gai YB, Wang W, et al. Summary of the best evidence for anticoagulation and bleeding risk management in patients with extracorporeal membrane oxygenation[J]. Chinese Critical Care Medicine, 2023, 35(9): 963-967.] DOI: 10.3760/cma.j.cn121430-20221018-00926.

47. 司向, 管向东. 体外膜肺氧合抗凝管理现状和挑战[J]. 中华医学杂志, 2022, 102(25): 1864-1869. [Si X, Guan XD. Current status and challenges of anticoagulation management in extracorporeal membrane oxygenation[J]. National Medical Journal of China, 2022, 102(25): 1864-1869.] DOI: 10.3760/cma.j.cn112137-20220223-00373.

48. Kamio T, Ikegami M, Mizuno M, et al. Machine learning-based prediction of bleeding risk in extracorporeal membrane oxygenation patients using transfusion as a surrogate marker[J]. Transfusion, 2025, 65(6): 1051-1060. DOI: 10.1111/trf.18261.

49. Parrett M, Yi C, Weaver B, et al. Nursing roles in extracorporeal membrane oxygenation[J]. Am J Nurs, 2024, 124(11): 30-37. DOI: 10.1097/01.NAJ.0001081100.87718.df.

50. Dorsey M, Phillips K, James L, et al. Decreased bleeding and thrombotic complications on extracorporeal membrane oxygenation support following an updated anticoagulation protocol[J]. JTCVS Open, 2024, 23: 199-209. DOI: 10.1016/j.xjon.2024.11.019.

51. 王春, 陈晓君. ECMO治疗期间出血及感染并发症的护理管理策略研究[J]. 护理学, 2025, 14(5): 669-674. [Wang C, Chen XJ. Nursing management strategy of bleeding and infection complications during ECMO treatment[J]. Nursing Science, 2025, 14(5): 669-674.] DOI: 10.12677/ns.2025.145089.

52. Haq SH, Pulver R, Begmatov H, et al. The novel application of surgiflo and successful hemostasis of refractory intrapulmonary hemorrhage in extracorporeal membrane oxygenation[J]. Crit Care Explor, 2025, 7(8): e1301. DOI: 10.1097/cce.0000000000001301.

53. Hong L, Hou C, Chen L, et al. Developing a competency framework for extracorporeal membrane oxygenation nurses: a qualitative study[J]. Nurs Open, 2023, 10(4): 2449-2463. DOI: 10.1002/nop2.1502.

54. Leffall B, Myers L, Holcomb JB, et al. Nursing care for extracorporeal membrane oxygenation in the trauma patient[J]. Crit Care Nurs Q, 2021, 44(2): 140-146. DOI: 10.1097/cnq.0000000000000348.

55. Calvo C, Salineros M, Diaz R, et al. Femoral shaft fracture osteosynthesis in a critically ill patient under extracorporeal membrane oxygenation (ECMO)[J]. SICOT J, 2016, 2: 23. DOI: 10.1051/sicotj/2016012.

56. Martucci G, Schmidt M, Agerstrand C, et al. Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study[J]. Lancet Respir Med, 2023, 11(3): 245-255. DOI: 10.1016/s2213-2600(22)00353-8.